We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$26.1B
AUM Growth
+$3.27B
Cap. Flow
+$3.71B
Cap. Flow %
14.22%
Top 10 Hldgs %
13.68%
Holding
2,527
New
200
Increased
1,494
Reduced
642
Closed
151

Sector Composition

Rank Sector Weight
1 Healthcare 9.16%
2 Technology 8.66%
3 Financials 8.59%
4 Industrials 7.31%
5 Consumer Staples 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MN
2451
DELISTED
MANNING & NAPIER, INC.
MN
-63,362
Closed -$824K
CDR
2452
DELISTED
Cedar Realty Trust, Inc
CDR
-7,956
Closed -$393K
ENBL
2453
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
-17,831
Closed -$292K
RAVN
2454
DELISTED
Raven Industries Inc
RAVN
-10,600
Closed -$217K
JTD
2455
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
-12,649
Closed -$202K
SNR
2456
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
-29,149
Closed -$485K
GLOG
2457
DELISTED
GASLOG LTD
GLOG
-45,376
Closed -$881K
CMD
2458
DELISTED
Cantel Medical Corporation
CMD
-23,919
Closed -$1.14M
PER
2459
DELISTED
SANDRIDGE PERMIAN TRUST
PER
-104,552
Closed -$743K
AGN
2460
DELISTED
Allergan plc
AGN
-255,311
Closed -$76M
INXN
2461
DELISTED
Interxion Holding N.V.
INXN
-43,884
Closed -$1.24M
PMR
2462
DELISTED
Invesco Dynamic Retail ETF
PMR
-31,508
Closed -$1.31M
PETX
2463
DELISTED
Aratana Therapeutics, Inc.
PETX
-18,460
Closed -$296K
LXFT
2464
DELISTED
Luxoft Holding, Inc.
LXFT
-18,650
Closed -$965K
KERX
2465
DELISTED
Keryx Biopharmaceuticals Inc
KERX
-19,624
Closed -$250K
WIN
2466
DELISTED
Windstream Holdings Inc
WIN
-49,693
Closed -$2.88M
IPXL
2467
DELISTED
Impax Laboratories, Inc.
IPXL
-16,886
Closed -$791K
BIOA
2468
DELISTED
BioAmber Inc.
BIOA
-24,548
Closed -$214K
SNAK
2469
DELISTED
Inventure Foods, Inc.
SNAK
-18,950
Closed -$212K
INVN
2470
DELISTED
Invensense Inc
INVN
-13,463
Closed -$205K
CEB
2471
DELISTED
CEB Inc.
CEB
-30,501
Closed -$2.44M
ELNK
2472
DELISTED
EarthLink Holdings Corp.
ELNK
-71,097
Closed -$316K
APOL
2473
DELISTED
Apollo Education Group Inc Class A
APOL
-156,078
Closed -$2.95M
PPS
2474
DELISTED
Post Properties
PPS
-17,473
Closed -$995K
PTX
2475
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
-2,325
Closed -$249K

Similar funds

Raymond James & Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Raymond James & Associates held 2,527 positions worth $26.1B, up 14% from $22.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Raymond James & Associates deployed $3.71B of net new capital in Q2 2015, opening 200 new positions and adding to 1,494 existing holdings. Its largest new stake was AMEC Foster Wheeler plc: 809,014 shares worth $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 9.2% of assets, down from 9.4% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Williams Companies, an estimated $47.1M trimmed.

  • Raymond James & Associates's largest Q2 2015 buy was AMEC Foster Wheeler plc: 809,014 shares worth $10.5M.
  • Raymond James & Associates added most to WisdomTree Europe Hedged Equity Fund in Q2 2015, an estimated $129M increase.
  • Raymond James & Associates's biggest Q2 2015 reduction was Williams Companies, cutting an estimated $47.1M.
  • Raymond James & Associates fully exited Allergan plc in Q2 2015, selling an estimated $76M.
  • Raymond James & Associates's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2015.
  • Raymond James & Associates opened 200 new positions and closed 151 in Q2 2015.
  • Raymond James & Associates's portfolio value rose 14% quarter-over-quarter to $26.1B.

Based on Raymond James & Associates's 13F filing for Q2 2015, filed 13 Aug 2015.